spacer
spacer

PDBsum entry 3kba

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transcription PDB id
3kba

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
244 a.a. *
Ligands
WOW ×2
SO4
Waters ×425
* Residue conservation analysis
PDB id:
3kba
Name: Transcription
Title: Progesterone receptor bound to sulfonamide pyrrolidine partial agonist
Structure: Progesterone receptor. Chain: a, b. Fragment: steroid-binding region: unp residues 681-933. Synonym: pr, nuclear receptor subfamily 3 group c member 3. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: pgr, nr3c3. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
2.00Å     R-factor:   0.197     R-free:   0.250
Authors: L.S.Kallander,D.G.Washburn,S.P.Williams,K.P.Madauss
Key ref: L.S.Kallander et al. (2010). Improving the developability profile of pyrrolidine progesterone receptor partial agonists. Bioorg Med Chem Lett, 20, 371-374. PubMed id: 19926282
Date:
20-Oct-09     Release date:   08-Dec-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P06401  (PRGR_HUMAN) -  Progesterone receptor from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
933 a.a.
244 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
Bioorg Med Chem Lett 20:371-374 (2010)
PubMed id: 19926282  
 
 
Improving the developability profile of pyrrolidine progesterone receptor partial agonists.
L.S.Kallander, D.G.Washburn, T.H.Hoang, J.S.Frazee, P.Stoy, L.Johnson, Q.Lu, M.Hammond, L.S.Barton, J.R.Patterson, L.M.Azzarano, R.Nagilla, K.P.Madauss, S.P.Williams, E.L.Stewart, C.Duraiswami, E.T.Grygielko, X.Xu, N.J.Laping, J.D.Bray, S.K.Thompson.
 
  ABSTRACT  
 
The previously reported pyrrolidine class of progesterone receptor partial agonists demonstrated excellent potency but suffered from serious liabilities including hERG blockade and high volume of distribution in the rat. The basic pyrrolidine amine was intentionally converted to a sulfonamide, carbamate, or amide to address these liabilities. The evaluation of the degree of partial agonism for these non-basic pyrrolidine derivatives and demonstration of their efficacy in an in vivo model of endometriosis is disclosed herein.
 

 

spacer

spacer